Unknown

Dataset Information

0

Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.


ABSTRACT: Ninety-four patients infected with carbapenem-resistant Acinetobacter baumannii were randomized to receive colistin alone or colistin plus fosfomycin for 7 to 14 days. The patients who received combination therapy had a significantly more favorable microbiological response and a trend toward more favorable clinical outcomes and lower mortality than those who received colistin alone. (This study has been registered at ClinicalTrials.gov under registration no. NCT01297894.).

SUBMITTER: Sirijatuphat R 

PROVIDER: S-EPMC4135862 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.

Sirijatuphat Rujipas R   Thamlikitkul Visanu V  

Antimicrobial agents and chemotherapy 20140630 9


Ninety-four patients infected with carbapenem-resistant Acinetobacter baumannii were randomized to receive colistin alone or colistin plus fosfomycin for 7 to 14 days. The patients who received combination therapy had a significantly more favorable microbiological response and a trend toward more favorable clinical outcomes and lower mortality than those who received colistin alone. (This study has been registered at ClinicalTrials.gov under registration no. NCT01297894.). ...[more]

Similar Datasets

| S-EPMC4462660 | biostudies-literature
| S-EPMC7242406 | biostudies-literature
2023-07-01 | GSE218219 | GEO
| S-EPMC8300792 | biostudies-literature
| S-EPMC7996625 | biostudies-literature
| S-EPMC6138847 | biostudies-literature
| S-EPMC8468411 | biostudies-literature
| S-EPMC6198730 | biostudies-literature
2021-01-12 | PXD020218 | Pride
| S-EPMC7751577 | biostudies-literature